Can a super antibiotic stop surgery infections?
NCT ID NCT07620223
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study tests whether giving a stronger antibiotic (piperacillin-tazobactam) before liver surgery can prevent surgical site infections better than the standard antibiotic (cefuroxime) in hospitals with high antibiotic resistance. About 378 adults having planned liver surgery will take part. The main goal is to see how many people get an infection within 30 days after surgery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Piperacillin-tazobactam
What this could lead to
If it works, this could show that a stronger antibiotic is better at preventing infections after liver surgery in hospitals where many germs are resistant to standard drugs.
What could go wrong
This is a single-center trial, so results may not apply everywhere. The stronger antibiotic may cause more side effects or not reduce infections significantly.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOBILIARY SURGERY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Nanjing Drum Tower Hospital
RECRUITINGNanjing, Jiangsu, 210008, China
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••